What is 351(k) biologics license application (BLA)?
Posted on29 Feb 2024
Comments0
351(k) biologics license application is the biosimilar application process in USFDA. Manufacturers must submit 351(k) biologics license application (BLA) to have a product reviewed as a... Read More








